Lebanese Interhospital Pneumococcal Surveillance Program

Launched by AMERICAN UNIVERSITY OF BEIRUT MEDICAL CENTER · May 13, 2009

Keywords

ClinConnect Summary

The Lebanese Interhospital Pneumococcal Surveillance Program is a clinical trial aimed at understanding which types of the pneumococcus bacteria are causing serious infections like pneumonia, meningitis, and sepsis in Lebanon. Researchers will collect samples from patients of all ages who have been hospitalized with these infections. These samples, taken from blood or spinal fluid, will help the team identify the specific types of bacteria and how they respond to different antibiotics. This information is crucial because it will help determine how effective current vaccines are in preventing these infections, particularly in children.

To participate in this study, patients must have confirmed cases of invasive pneumococcal infections. This includes anyone who has had positive test results from their blood or other sterile body sites. The study is open to individuals of all ages, and samples will be collected from hospitals across Lebanon. By sharing the findings with doctors and the Ministry of Health, the researchers aim to improve health outcomes for patients facing these serious infections.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Samples included in the study are those that are:
• • culture proven
• • invasive pneumococcal infections
• • in patients of all ages admitted to different hospitals all over Lebanon
• * Acceptable samples include:
• • positive isolates from blood
• • cerebrospinal fluid
• • other normally sterile body sites such as empyema fluid, abscesses, joint fluid, middle ear fluid obtained by tympanocentesis in the operating room, and lung needle aspiration
• Exclusion Criteria:
• • non S. pneumoniae isolates